Comparison

Lyn peptide inhibitor acetate European Partner

Item no. TMO-TP2008L-50mg
Manufacturer TargetMol
CASRN TP2008L
Amount 50 mg
Quantity options 100 mg 10 mg 1 mg 200 mg 25 mg 50 mg 5 mg
Category
Type Peptides
Specific against other
Smiles CCCCCCCCCCCCCCCCCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1CCC[C@H]1C(N[C@H](C(N2CCC[C@H]2C(N)=O)=O)CC(N)=O)=O)=O)[C@H](CC)C)=O)CCCCN)=O)CCC(O)=O)=O)CCC(O)=O)=O)CC3=CNC4=CC=CC=C43)=O)CCCCN)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CC(C)C)=O)CCCNC(N)=N)=O)CC5=CC=C(O)C=C5)=O)=O)CC6=CC=C(O)C=C6)=O.CC(O)=O
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Lyn peptide inhibitor acetate(222018-18-0 free base)
Shipping Condition Cool pack
Available
Manufacturer - Targets
IL Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
2430.98
Description
Lyn peptide inhibitor acetate is a potent and cell-permeable inhibitor of Lyn-coupled IL-5 receptor signaling pathway, while keeping other signals intact. Lyn peptide inhibitor blocks Lyn activation and inhibits the binding of Lyn tyrosine kinase to βc subunit of IL-3/GM-CSF/IL-5 receptors. Lyn peptide inhibitor can be used for study of asthma, allergic, and other eosinophilic disorders.
Pathways
Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close